H-CYTE, Inc. (HCYT)
|Net Income (ttm)||-6.78M|
|Trading Day||May 3|
|Day's Range||0.0466 - 0.0507|
|52-Week Range||0.0060 - 0.1500|
There are no news available yet.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute biologics for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
|Stock Exchange |
|Ticker Symbol |
In 2020, H-CYTE, Inc.'s revenue was $2.15 million, a decrease of -74.23% compared to the previous year's $8.35 million. Losses were -$6.46 million, -78.33% less than in 2019.